Description
Recombinant monoclonal antibody to CD18. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YFC51.1. This chimeric human antibody was made using the variable domain sequences of the original Rat IgG2b format for improved compatibility with existing reagents assays and techniques.
Target
CD18
Target Alias Names
ITGB2, MFI7, Integrin beta-2, Cell surface adhesion glycoproteins LFA-1/CR3/p150.95 subunit beta, Complement receptor C3 subunit beta, β2-subunit of leukocyte integrins
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression